Page last updated: 2024-09-03

dioctanoylphosphatidic acid and vpc32183

dioctanoylphosphatidic acid has been researched along with vpc32183 in 1 studies

Compound Research Comparison

Studies
(dioctanoylphosphatidic acid)
Trials
(dioctanoylphosphatidic acid)
Recent Studies (post-2010)
(dioctanoylphosphatidic acid)
Studies
(vpc32183)
Trials
(vpc32183)
Recent Studies (post-2010) (vpc32183)
13021112

Protein Interaction Comparison

ProteinTaxonomydioctanoylphosphatidic acid (IC50)vpc32183 (IC50)
Lysophosphatidic acid receptor 1Homo sapiens (human)0.992

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Billon-Denis, E; Robin, P; Violet, PC1

Other Studies

1 other study(ies) available for dioctanoylphosphatidic acid and vpc32183

ArticleYear
Inhibition of lipid phosphate phosphatase activity by VPC32183 suppresses the ability of diacylglycerol pyrophosphate to activate ERK(1/2) MAP kinases.
    Biochimica et biophysica acta, 2012, Volume: 1821, Issue:11

    Topics: Blotting, Western; Cell Membrane; Cells, Cultured; Diphosphates; Glycerol; Humans; Hydrolysis; Kidney; Lysophospholipids; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Organophosphates; Phosphatidate Phosphatase; Phosphatidic Acids; Phosphorylation; Protein Kinase C; Pyridines; raf Kinases; Real-Time Polymerase Chain Reaction; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2012